NCT04147507

Brief Summary

Prehypertention is defined as systolic blood pressure between 120 and 139 mmHg and/or diastolic blood pressure between 80 and 89 mmHg. People with prehypertension have the higher risk to develop hypertension compared to people with normal blood pressure (normotensive) especially when getting old, therefore prehypertension is known for preliminary stage of hypertension. Framingham Heart Study have shown the progression rate from prehypertension to hypertension was as high as 19% over 4 years. Prehypertension will also lead to abnormality of the cardiovascular system. Thus it is very important to identify the prehypertension at early stage, so that steps can be taken to slow down the progression to hypertension and to normalize the blood pressure level. Minimal reduction in blood pressure produce a large benefit to human health, as stated in JNC (Joint National Committee) VII report, a 5mmHg decrease in systolic blood pressure would be able to reduce as much as 9% mortality rate caused by coronary heart disease, 14% mortality related to stroke, and 7% decrease in all-cause mortality. Previous studies have focused on effect of music therapy in hypertensive elderly, prehypertensive pregnant women, prehypertensive elderly but no research has been conducted on prehypertensive young adults. In addition, prehypertension increase risk of developing cardiovascular disease, thus early intervention is needed to prevent the progression of prehypertension to hypertension status and normalize the blood pressure level.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 29, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 1, 2019

Completed
3 months until next milestone

Study Start

First participant enrolled

February 10, 2020

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 14, 2020

Completed
7 days until next milestone

Study Completion

Last participant's last visit for all outcomes

September 21, 2020

Completed
Last Updated

November 24, 2020

Status Verified

November 1, 2020

Enrollment Period

7 months

First QC Date

October 29, 2019

Last Update Submit

November 22, 2020

Conditions

Outcome Measures

Primary Outcomes (3)

  • Systolic Blood Pressure change is being measured

    At baseline (before intervention) and post intervention (end of 4 weeks)

  • Diastolic Blood Pressure change is being measured

    At baseline (before intervention) and post intervention (end of 4 weeks)

  • Resting Heart Rate change is being measured

    At baseline (before intervention) and post intervention (end of 4 weeks)

Study Arms (2)

Music Therapy

EXPERIMENTAL
Other: Passive Music Therapy

Control

OTHER

Life style Modification.

Behavioral: Control

Interventions

Music group (N=15) will receive listen to music therapy passively for 20 minutes/day, 5 days/week for 4 weeks, along with lifestyle modifications. Music therapy will be provided via headphones in an isolated quiet non-disrupted room, with room temperature maintained between 20-22 degree Celsius and having medium light intensity. Participants would be instructed to listen to music with eyes closed in sitting position, back supported in comfortable position on a chair. The participants will be given 5 minutes' rest in sitting position before and after each music therapy session.

Music Therapy
ControlBEHAVIORAL

Control group (N=15) would receive only lifestyle modification. Handout of lifestyle modification according to the Seventh Joint National Committee (JNC VII) report guidelines will be given to all participants. Participants would be instructed to not participate in any form of physical activity and to focus only on two components from the guideline which includes practice the DASH eating plan (diet rich in fruits and vegetables, low fat dairy or unsaturated fat) and limit the daily sodium intake (less than 100 mmol per day).

Control

Eligibility Criteria

Age18 Years - 25 Years
Sexmale(Gender-based eligibility)
Gender Eligibility DetailsOnly male participants with prehypertension.
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Systolic blood pressure between 120 to 139 mmHg
  • Diastolic blood pressure between 80 to 89 mmHg
  • Not having any hearing impairment and able to listen to music using headphone
  • Willing to participate in this study

You may not qualify if:

  • Under influence of any medication that would affect the concentration
  • Systolic Blood pressure of less than 120 or more than 140 mmHg
  • Diastolic blood pressure of less than 80 or more than 90 mmHg

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universiti Tunku Abdul Rahman

Kajang, Selangor, 43000, Malaysia

Location

MeSH Terms

Conditions

Prehypertension

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 29, 2019

First Posted

November 1, 2019

Study Start

February 10, 2020

Primary Completion

September 14, 2020

Study Completion

September 21, 2020

Last Updated

November 24, 2020

Record last verified: 2020-11

Data Sharing

IPD Sharing
Will not share

No plan to make individual participant data (IPD) available to other researchers

Locations